Registration required for domestic sale in Portugal. Full pharmaceutical dossier required. Processing approximately 12–18 months.
Full pharmaceutical dossier
EU-GMP Part I certificate
Clinical data / bibliographic evidence
Product Dossier Preparation
Full pharmaceutical dossier including quality, safety, and efficacy data. May use bibliographic evidence for well-established use applications.
Quality module (EU CTD format)
Non-clinical and clinical data
GMP/GACP certificates
Proposed SmPC and labeling
Environmental risk assessment
INFARMED Product Registration
Submission to INFARMED. Full pharmaceutical review. Processing approximately 12–18 months.
EU CTD-format dossier
Proposed Portuguese labeling
Risk management plan
Processing: approximately 12–18 months
Registration approved?
INFARMED reviews the dossier and may request additional data or clarification during the review process.
Product Registered ✓
Product registered for sale in Portuguese pharmacies and hospitals. May also pursue mutual recognition or decentralized procedure for other EU markets.